BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36722677)

  • 1. Application of nano-antibiotics in the diagnosis and treatment of infectious diseases.
    Al-Awsi GRL; Alameri AA; Al-Dhalimy AMB; Gabr GA; Kianfar E
    Braz J Biol; 2023; 84():e264946. PubMed ID: 36722677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active targeted drug delivery for microbes using nano-carriers.
    Lin YS; Lee MY; Yang CH; Huang KS
    Curr Top Med Chem; 2015; 15(15):1525-31. PubMed ID: 25877093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silver nanoparticles as potential antibacterial agents.
    Franci G; Falanga A; Galdiero S; Palomba L; Rai M; Morelli G; Galdiero M
    Molecules; 2015 May; 20(5):8856-74. PubMed ID: 25993417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable chitosan nanoparticles in drug delivery for infectious disease.
    Landriscina A; Rosen J; Friedman AJ
    Nanomedicine (Lond); 2015 May; 10(10):1609-19. PubMed ID: 26008195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles: Alternatives Against Drug-Resistant Pathogenic Microbes.
    Rudramurthy GR; Swamy MK; Sinniah UR; Ghasemzadeh A
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27355939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid Nanosystems of Antibiotics with Metal Nanoparticles-Novel Antibacterial Agents.
    Shabatina TI; Vernaya OI; Melnikov MY
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles for Antimicrobial Agents Delivery-An Up-to-Date Review.
    Mercan DA; Niculescu AG; Grumezescu AM
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Countering drug resistance, infectious diseases, and sepsis using metal and metal oxides nanoparticles: Current status.
    Khan ST; Musarrat J; Al-Khedhairy AA
    Colloids Surf B Biointerfaces; 2016 Oct; 146():70-83. PubMed ID: 27259161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current State of Nanomedicines in the Treatment of Topical Infectious Disorders.
    Thakur K; Sharma G; Singh B; Chhibber S; Katare OP
    Recent Pat Antiinfect Drug Discov; 2018; 13(2):127-150. PubMed ID: 29807522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colloid particle formulations for antimicrobial applications.
    Halbus AF; Horozov TS; Paunov VN
    Adv Colloid Interface Sci; 2017 Nov; 249():134-148. PubMed ID: 28528626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Antibacterial Mechanism of Silver Nanoparticles and Its Application in Dentistry.
    Yin IX; Zhang J; Zhao IS; Mei ML; Li Q; Chu CH
    Int J Nanomedicine; 2020; 15():2555-2562. PubMed ID: 32368040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal and Metal Oxide Nanoparticle as a Novel Antibiotic Carrier for the Direct Delivery of Antibiotics.
    Kotrange H; Najda A; Bains A; Gruszecki R; Chawla P; Tosif MM
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale.
    Dreaden EC; El-Sayed MA
    Acc Chem Res; 2012 Nov; 45(11):1854-65. PubMed ID: 22546051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Silver Nanoparticles on Multiple Drug-Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa from Mastitis-Infected Goats: An Alternative Approach for Antimicrobial Therapy.
    Yuan YG; Peng QL; Gurunathan S
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver nanoparticles as potential antiviral agents.
    Galdiero S; Falanga A; Vitiello M; Cantisani M; Marra V; Galdiero M
    Molecules; 2011 Oct; 16(10):8894-918. PubMed ID: 22024958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles as Novel Emerging Therapeutic Antibacterial Agents in the Antibiotics Resistant Era.
    Fatima F; Siddiqui S; Khan WA
    Biol Trace Elem Res; 2021 Jul; 199(7):2552-2564. PubMed ID: 33030657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.
    Jain J; Arora S; Rajwade JM; Omray P; Khandelwal S; Paknikar KM
    Mol Pharm; 2009; 6(5):1388-401. PubMed ID: 19473014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Combined Macrolide Nanomaterials are Effective Against Resistant Pathogens? A Comprehensive Review of the Literature.
    Siraj EA; Yayehrad AT; Belete A
    Int J Nanomedicine; 2023; 18():5289-5307. PubMed ID: 37732155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancements in Nanotechnology for Enhanced Antifungal Drug Delivery: A Comprehensive Review.
    Srivastava R; Rawat AKS; Mishra MK; Patel AK
    Infect Disord Drug Targets; 2024; 24(2):e021123223053. PubMed ID: 38291868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.